The largest State-wide epidemiological study on Hepatocellular Carcinoma (HCC) or liver cancer, completed throughout 15 main hospitals in Kerala, has reported cirrhosis brought on by non-alcoholic fatty liver disease (NAFLD) to be the predominant aetiology of liver cancer in Kerala.
The study, which analysed the info of 1,217 sufferers with HCC from throughout Kerala between May 2018 to April 2020, reported cirrhosis related to NAFLD to be the direct cause in 44% sufferers, adopted intently by alcohol abuse, in 40% circumstances.
Hepatitis B virus was the cause in 7% circumstances and Hepatitis C virus, in 4% circumstances of HCC.
Among danger elements, Diabetes mellitus was current in 64% sufferers with HCC, excessive cholesterolemia in 17% and hypertension in 38%. About 33% of the sufferers had been overweight (BMI >25) and 15% had been obese. Non-alcoholic fatty liver disease (NAFLD) with or with out metabolic syndrome was current in 44%. HCC was extra frequent in males (90%) than in ladies
“Multi-center prospective survey of hepatocellular carcinoma in Kerala: More than 1,200 cases”, seems in the newest challenge of Indian Journal of Gastroenterology, the official journal of the Indian Society of Gastroenterology.
The study is essential from the Indian perspective as a result of there is no such thing as a nationwide or State consultant information on the epidemiology of HCC. The crude annual incidence fee of HCC in India in 2015 was 2.8 circumstances per lakh inhabitants.
From the general public well being perspective, the info has big implications for a State like Kerala the place the diabetes prevalence is estimated to be 35% and that of pre-diabetes, 15%.
ALSO READ | Manathakkali holds hope for liver cancer sufferers
Rising ranges of metabolic syndrome (a cluster of circumstances which embody diabetes, hypertension, ldl cholesterol and triglyceride ranges and belly weight problems that happen collectively and may enhance one’s danger of coronary heart disease and stroke) in the inhabitants has been a priority in the State for the reason that 90s, the incidence of which has been steadily growing.
NAFLD is the liver manifestation of metabolic syndrome. It encompasses a spectrum of illnesses from gentle steatosis (fatty adjustments in the liver) to non-alcoholic steatohepatitis (NASH or aggressive fatty liver disease) and inflammatory scarring which can progress to cirrhosis and liver failure. NAFLD, whereas it’s progressive, can be modifiable by means of a nutritious diet and enough bodily exercise
“Viral hepatitis is no longer an important etiology of liver cancer in Kerala, thanks to the successful vaccination against Hepatitis B and the curative antiviral therapy against Hepatitis C. The fact that a significant proportion of those with NAFLD is progressing to liver cancer, with or without cirrhosis, signals the importance of preventive strategies to check the spiralling levels of metabolic syndrome in the population,” says Cyriac Abby Philips, senior guide Hepatologist and physician-scientist on the Liver Institute, Rajagiri Hospital, Kochi, who was half of the study group
In the study, 48% of the sufferers offered with very superior disease and acquired solely palliation. The tumour was greater than 5 cm in 59%, portal vein invasion was seen in 33% and metastasis, in 16%. Around 52% of sufferers might obtain particular remedy. Liver transplantation inside suggestions improved survival probably the most, than liver resection or localized chemotherapy utilizing transarterial chemoembolization.
“NAFLD is not a trivial diagnosis. If one has other associated risk factors such as diabetes, overweight/obesity or mild/moderate use of alcohol — it can predispose one to develop liver cancer with or without chronic liver disease. Severe fatty inflammation and scarring (fibrosis) of the liver in the absence of fully developed cirrhosis is also a major risk factor for liver cancer. It is also one of the reasons why patients present themselves at advanced stages of HCC, identified only when they become symptomatic, and when few therapeutic options can be offered,” says Dr. Philips.
It is essential that the general public is given a greater understanding of NAFLD, which most individuals are fairly dismissive about, as “some fat in the liver”, he provides
The study is a pointer that the State might want to lay extra emphasis on controlling life-style illnesses, particularly diabetes and weight problems, to stop the incidence of liver cancer. As NAFLD, particularly NASH, can result in HCC with or with out cirrhosis in the liver, screening solely sufferers with cirrhosis could also be insufficient for early detection.